April 2012 Drug Information Update - Pharmacy Benefits ...

More documents

Recommendations

Info

• Pfizer launched paclitaxel 100 mg and 300 mg vials in March, 2012 and will launch 30 mg vials in April, 2012. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=790 Source: www.ashp.org Doxorubicin Injection March 15, 2012 Products Affected - Description Doxorubicin solution for injection, 2 mg/mL, Teva 5 mL vial (NDC 00703-5043-03) 25 mL vial (NDC 00703-5046-01) 100 mL vial (NDC 00703-5040-01) Adriamycin solution for injection, 2 mg/mL, Bedford 5 mL vial (NDC 55390-0235-10) 10 mL vial (NDC 55390-0236-10) 25 mL vial (NDC 55390-0237-01) 100 mL vial (NDC 55390-0238-01) Doxorubicin solution for injection, 2 mg/mL, Bedford Novaplus 5 mL vial (NDC 55390-0245-10) Novaplus 10 mL vial (NDC 55390-0246-10) Novaplus 25 mL multi-dose vial (NDC 55390-0247-01) Novaplus 100 mL multi-dose vial (NDC 55390-0248-01) Adriamycin lyophilized powder, Bedford 10 mg vials (NDC 55390-0231-10) 20 mg vials (NDC 55390-0232-10) 50 mg vial (NDC 55390-0233-01) Doxorubicin lyophilized powder, Bedford Novaplus 10 mg vial (NDC 55390-0241-10) Novaplus 50 mg vial (NDC 55390-0243-01) Reason for the Shortage • Ben Venue voluntarily suspended all manufacturing and distribution in mid-November, 2011. Product will become available in stages as production resumes. • Bedford Laboratories has multiple products affected by this suspension of manufacturing. Availability of all products, including those not manufactured at Ben Venue, is updated as information changes on the Bedford Laboratories website. • Teva has doxorubicin on shortage due to manufacturing issues. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=464 Source: www.ashp.org Choline Magnesium Trisalicylate March 15, 2012 Products Affected - Description Choline Magnesium Trisalicylate, Caraco 500 mg tablets, 100 count (NDC 57664-0219-08) - discontinued 750 mg tablets, 100 count (NDC 57664-0220-08) - discontinued 1000 mg tablets, 100 count (NDC 57664-0221-08) - discontinued Choline Magnesium Trisalicylate, Marlex 500 mg tablets, 100 count (NDC 10135-0467-01) 46
750 mg tablets, 100 count (NDC 10135-0468-01) Reason for the Shortage • Caraco has discontinued their product. Product was recently seized by US Marshals due to good manufacturing practice violations (see news release for more information). • Marlex could not provide a reason for their shortage. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=556 Source: www.ashp.org Oxycodone Immediate Release Tablets and Capsules March 16, 2012 Products Affected - Description Immediate Release Tablets Oxycodone Immediate-Release Tablets, Qualitest 5 mg tablets, 100 count (NDC 00603-4990-21) 5 mg tablets, 500 count (NDC 00603-4990-28) 15 mg tablets, 100 count (NDC 00603-4991-21) 15 mg tablets, 500 count (NDC 00603-4991-28) 30 mg tablets, 100 count (NDC 00603-4992-21) 30 mg tablets, 500 count (NDC 00603-4992-28) Oxycodone Immediate-Release Tablets, Caraco 15 mg tablets, 100 count (NDC 57664-0187-88) 30 mg tablets, 100 count (NDC 57664-0224-88) Immediate Release Capsules Oxycodone Immediate-Release Capsules, Mallinckrodt 5 mg capsules, 100 count (NDC 00406-0554-01) - discontinued Oxycodone Immediate-Release Capsules, MidLothian Labs 5 mg, 100 count (NDC 68308-0145-10) - discontinued Reason for the Shortage • Caraco, Mallinckrodt, Qualitest, and Xanodyne could not provide a reason for the shortage. • Mallinckrodt discontinued their oxycodone immediate-release 5 mg capsules in May, 2011. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=509 Source: www.ashp.org Vinblastine Injection March 20, 2012 Products Affected - Description Vinblastine lyophilized powder for injection, Bedford 10 mg vial (NDC 55390-0091-10) Vinblastine sulfate injection, APP 1 mg/mL, 10 mL vial (NDC 63323-0278-10) Reason for the Shortage • Ben Venue voluntarily suspended all manufacturing and distribution in mid-November, 2011. Product will become available in stages as production resumes. • Bedford Laboratories has multiple products affected by this suspension of manufacturing. Availability of all products, including those not manufactured at Ben Venue, is updated as information changes on the Bedford Laboratories website. • APP has their product in short supply due to increased demand for the product and a manufacturing delay. 47
Page 1 and 2: April 2012 Drug Information Update
Page 3 and 4: First-Time Generics GENERIC DRUG NA
Page 5 and 6: GENERAL ANESTHETICS, INJECTABLE MID
Page 7 and 8: Gruenhaupt, Mark R.Ph. Argus Health
Page 9 and 10: Statin Drugs - Drug Safety Communic
Page 11 and 12: Vytorin (ezetimibe/simvastatin) Tab
Page 13 and 14: low blood sugar (hypoglycemia) in p
Page 15 and 16: Some women with depression who beco
Page 17 and 18: Survival increased for all groups o
Page 19 and 20: finding that it also may reduce the
Page 21 and 22: Syringes (2 mL size), Rx only. NDC
Page 23 and 24: Patheon Pharmaceuticals Inc., Cinci
Page 25 and 26: 50-ct. bottles (NDC 0067-6238-50);
Page 27 and 28: PRODUCT (Class II) 1) Ventolin HFA
Page 29 and 30: Lot #: 0693, Exp: 10/2012 RECALLING
Page 31 and 32: 24 (Display case UPC# 3030045074923
Page 33 and 34: CODE Lot # 139961 RECALLING FIRM/MA
Page 35 and 36: Reason for the Shortage • Teva co
Page 37 and 38: Reason for the Shortage • Ben Ven
Page 39 and 40: Products Affected - Description Gan
Page 41 and 42: 37.5 mg/25 mg, 1000 count (NDC 0078
Page 43 and 44: Acyclovir tablets, Major 400 tablet
Page 45: 500 mg, 100 count (NDC 63304-0726-0
Page 49 and 50: • Bedford Laboratories has multip
Page 51 and 52: Daunorubicin Hydrochloride Injectio
Page 53 and 54: Ciprofloxacin Immediate-Release Tab
Page 55 and 56: • APP had tobramycin 40 mg/mL pre
Page 57 and 58: • Ben Venue voluntarily suspended
Page 59 and 60: 50 mg/mL, 10 mL vial, package of 10
Page 61 and 62: 2 mL vial, preservative-free (NDC 6
Page 63 and 64: 5 mg single dose vial, package of 1
Page 65 and 66: 20 mL glass ampule, sterile pack (N
Page 67 and 68: 2 mL iSecure syringe (NDC 00406-112
Page 69 and 70: Lidocaine 0.5% Xylocaine 0.5% injec
Page 71 and 72: • Teva discontinued all ciproflox
Page 73 and 74: Nicardipine hydrochloride injection
Page 75 and 76: Article link: http://www.ashp.org/D
Page 77 and 78: • Apotex had metformin products u
Page 79: • Covis purchased all rights to F

April 2012 Drug Information Update - Pharmacy Benefits ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?